Osteoporose – die unterschätzte und untertherapierte
                    Volkskrankheit

Uwe Gröber; Hans-Peter Friedrichsen; Klaus Kisters

doi:10.1055/a-1817-8383

Zeitschrift für Orthomolekulare Medizin, Table of Contents

Zeitschrift für Orthomolekulare Medizin 2022; 20(02): 4-13
DOI: 10.1055/a-1817-8383

Wissen

Osteoporose – die unterschätzte und untertherapierte Volkskrankheit

Uwe Gröber

,

Hans-Peter Friedrichsen

,

Klaus Kisters

Abstract

Zusammenfassung

Osteoporose ist eine Skeletterkrankung, die durch ein Missverhältnis in der Aktivität der knochenauf- und -abbauenden Zellen, einer niedrigen Knochenmasse mit Verschlechterung der Mikroarchitektur des Knochengewebes gekennzeichnet ist. Sie manifestiert sich durch dünne Knochen mit einem hohen Risiko für Knochenbrüche. Zur Prävention und Therapie gehört neben einer kalziumreichen Ernährung und regelmäßiger körperlicher Aktivität auch eine adäquate Versorgung des Organismus mit einem komplexen Spektrum knochenrelevanter Mikronährstoffe.

Schlüsselwörter

Osteoporose - Knochen - knochengesunde Ernährung - Vitamin D - Kalzium - Bisphonate - Vitamin A - Vitamin K - Vitamin C - Vitamin B₆ - B₉ und B₁₂ - Magnesium - Kalium - Zink - Mangan - Kupfer - Bor - ω-3-Fettsäuren - Aminosäuren

Full Text

References

Literatur
1 Bartl R.. Osteoporosis – risk factors and prevention program. Pharmakon 2019; 7: 250-257
2 Bartl R.. Aktuelle Osteoporoseprophylaxe und -therapie. Frakturorientiert, effektiv, nebenwirkungsarm, kostengünstig. Internist 2015; 56: 1445-1457
3 Bartl R, Schöps P, Bartl C.. Osteoporosis – Pain relief first!. MMW Fortschr Med 2015; 157: 59-62
4 Bartl R, Gradinger R.. Current diagnosis and therapy of osteoporosis on the basis of "European guidance 2008". Orthopäde 2009; 38: 365-379
5 Rizzoli R, Stevenson JC, Bauer JM. et al. ESCEO Task Force. The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Maturitas 2014; 79: 122-132
6 Nowson C, O’Connell S.. Protein requirements and recommendations for older people: A review. Nutrients 2015; 7: 6874-6899
7 Cashman KD, Dowling KG, Skrabakova Z. et al. Vitamin D deficiency in Europe: pandemic?. Am J Clin Nutr 2016; 103: 1033-1044
8 Borsche L, Glauner B, von Mendel J.. COVID-19 Mortality Risk Correlates Inversely with Vitamin D3 Status, and a Mortality Rate Close to Zero Could Theoretically Be Achieved at 50 ng/mL 25(OH)D3: Results of a Systematic Review and Meta-Analysis. Nutrients 2021; 13: 3596
9 Bischoff-Ferrari HA, Willet WC, Orav EJ. et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med 2012; 367: 40-49
10 Liu C, Kuang X, Li K. et al. Effects of combined calcium and vitamin D supplementation on osteoporosis in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials. Food Funct 2020; 11: 10817-10827
11 Yao P, Bennett D, Mafham M. et al. Vitamin D and Calcium for the Prevention of Fracture. A Systematic Review and Meta-analysis. JAMA Netw Open 2019; 2: e1917789
12 DACH. Referenzwerte für die Nährstoffzufuhr – Vitamin D. Bonn, 2008
13 Wacker M, Holick MF.. Vitamin D-Effects on skeletal and extraskeletal health and the need for supplementation. Nutrients 2013; 5: 111-148
14 Bruyere O, Reginster JY.. Vitamin D status and response to antiosteoporotic therapy. Womens Health 2008; 4: 445-447
15 Adami S. et al. Vitamin D status and response to treatment in post-menopausal osteoporosis. Osteoporos Int 2009; 20: 239-244
16 Bedogni A, Saia G, Bettine G. et al. Osteomalacia: the missing link in the pathogenesis of bisphosphonate-related osteonecrosis of the jaws?. The Oncologist 2012; 17: 1114-1119
17 Favus MJ.. Bisphosphonates for osteoporosis. N Engl J Med 2010; 363: 2027-2035
18 Heaney RP.. Vitamin D in health and disease. Clin J Am Soc Nephrol 2008; 3: 1535-1541
19 Gröber U, Holick MF.. Vitamin D – die Heilkraft des Sonnenvitamins. 4., aktual. u. erw. Aufl. Stuttgart: Wissenschaftliche Verlagsgesellschaft;; 2020
20 Domarus C, Brown J, Barvencik F. et al. How Much Vitamin D Do We Need for Skeletal Health?. Clin Orthop Relat Res 2011; 469: 3127-3133
21 Henning P, Conaway HH, Lerner UH.. Retinoid receptors in bone and their role in bone remodelling. Front Endocrinol (Lausanne) 2015; 6: 31
22 Yee MMF, Chin KY, Ima-Nirwana S. et al. Vitamin A and Bone Health: A Review on Current Evidence. Molecules 2021; 26: 1757
23 Cancela ML, Price PA.. Retinoic acid induces matrix Gla protein gene expression in human cells. Endocrinology 1992; 130: 102-108
24 Jääskeläinen T, Ryhänen S, Mäenpää P.. 9-cis retinoic acid accelerates calcitriol-induced osteocalcin production and promotes degradation of both vitamin D receptor and retinoid X receptor in human osteoblastic cells. J Cell Biochem 2003; 89: 1164-1176
25 Arbour NC, DeLuca HF. et al. Transcriptional control of the osteocalcin gene by 1,25-dihydroxyvitamin D-2 and its 24 epimer in rat osteosarcoma cells. Biochem Biophys Acta 1995; 1263: 147-153
26 Gröber U, Kisters K.. Vitamin K – Ein altes Vitamin im neuen Licht. 4. Aufl.. Stuttgart: Wissenschaftliche Verlagsgesellschaft; 2021
27 Knapen MH, Drummen NE, Smit E. et al. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporos Int 2013; 24: 2499-2507
28 Sato T, Inaba N, Yamashita T.. MK-7 and Its Effects on Bone Quality and Strength. Nutrients 2020; 12: 965
29 Gröber U, Kisters K.. Vitamin K in Prävention und Therapie. EHK 2016; 65: 184-191
30 Gröber U, Kisters K.. Vitamin D niemals ohne Vitamin K₂ – Imperativ oder Konjunktiv?. EHK 2018; 67: 226-230
31 Hu L, Ji J, Li D. et al. The combined effect of vitamin K and calcium on bone mineral density in humans: a meta-analysis of randomized controlled trials. J Orthop Surg Res 2021; 16: 592
32 Sato Y, Honda Y, Iwamoto J. et al. Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA 2005; 293: 1082-1088
33 Sugiyama T, Tanaka H, Taguchi T.. Folate and vitamin B₁₂ for hip fracture prevention after stroke. JAMA 2005; 294: 792
34 Saito M, Marumo K.. The Effects of Homocysteine on the Skeleton. Curr Osteoporos Rep 2018; 16: 554-560
35 Gröber U, Schmidt J, Kisters K.. Magnesium in Prevention and Therapy. Nutrients 2015; 7: 8199-8226
36 Barbagallo M, Veronese N, Dominguez LJ.. Magnesium in Aging, Health and Diseases. Nutrients 2021; 13: 463
37 Kisters K, Gröber U, Westhoff T. et al. Increased serum vitamin D concentration under oral magnesium therapy in elderly hypertensives. Magnes Res 2020; 33: 131-132
38 Capozzi A, Scambia G, Lello S.. Calcium, vitamin D, vitamin K₂, and magnesium supplementation and skeletal health. Maturitas 2020; 140: 55-63
39 Granchi D, Torreggiani E, Massa A. et al. Potassium citrate prevents increased osteoclastogenesis resulting from acidic conditions: Implication for the treatment of postmenopausal bone loss. PLoS One 2017; 12: e0181230
40 Strause L, Saltman P, Smith KT.. Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals. J Nutr 1994; 124: 1060-1064
41 Gröber U, Kisters K.. Das Ultraspurenelement Bor. Zeitschr f Orthomol Med 2015; 4: 9-15
42 Rozner R, Vernikov J, Griess-Fishheimer S. et al. The Role of Omega-3 Polyunsaturated Fatty Acids from Different Sources in Bone Development. Nutrients 2020; 12: 3494
43 Torricelli P, Fini M, Giavaresi G. et al. L-arginine and L-lysine stimulation on cultured human osteoblasts. Biomed Pharmacother 2002; 56: 492-497
44 Jennings A, MacGregor A, Spector T. et al. Amino Acid Intakes Are Associated With Bone Mineral Density and Prevalence of Low Bone Mass in Women: Evidence From Discordant Monozygotic Twins. J Bone Miner Res 2016; 31: 326-335
45 Yang T, Lee SY, Park KC. et al. The Effects of Selenium on Bone Health: From Element to Therapeutics. Molecules 2022; 27: 392